immuno-oncology therapeutics (Amgen)

N/A

Report date: 2025/03/20 15:01:57

Base Information

Drug Nameimmuno-oncology therapeutics (Amgen)
Drug Alias Nameimmuno-oncology therapeutics (Five Prime Therapeutics)
ClassificationBiologics
Mechanisms of ActionImmunostimulants
TargetsUpdating
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesFive Prime Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesAmgen Inc
Inactive CompaniesFive Prime Therapeutics Inc
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A